Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDNovartis AG Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | $2.06 | $2.15 | $2.10 |
| Q2 2026 | 2 | $2.09 | $2.23 | $2.17 |
| Q3 2026 | 2 | $2.21 | $2.28 | $2.26 |
| Q4 2026 | 1 | $2.16 | $2.30 | $2.23 |
| Q1 2027 | 1 | $2.23 | $2.38 | $2.31 |
| Q2 2027 | 1 | $2.30 | $2.45 | $2.38 |
| Q3 2027 | 1 | $2.34 | $2.49 | $2.42 |
| Q4 2027 | 1 | $2.36 | $2.52 | $2.44 |
Novartis AG Earnings Date And Information
Novartis AG last posted its earnings results on Tuesday, April 28th, 2026. The company reported $1.99 earnings per share for the quarter, missing analysts' consensus estimates of $2.11 by $0.12. The company had revenue of 13.52 B for the quarter and had revenue of 54.81 B for the year. Novartis AG has generated $7 earnings per share over the last year ($7.19 diluted earnings per share) and currently has a price-to-earnings ratio of 21.59. Novartis AG has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Novartis AG Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/28/2026 | Q1 2026 | $2.11 | $1.65 | -0.46 | $13.44 B | $13.52 B |
| 02/04/2026 | Q4 2025 | $1.99 | $1.26 | -0.73 | $13.70 B | $13.33 B |
| 10/28/2025 | Q3 2025 | N/A | $2.04 | N/A | N/A | $14.36 B |
| 07/17/2025 | Q2 2025 | $2.38 | $2.07 | -0.31 | $14.07 B | $14.84 B |
| 03/31/2025 | Q1 2025 | N/A | $1.83 | N/A | $13.08 B | $13.62 B |
| 01/31/2025 | Q4 2024 | $1.80 | $1.42 | -0.38 | $12.84 B | $13.56 B |
| 09/28/2024 | Q3 2024 | N/A | $1.58 | N/A | $12.79 B | $13.17 B |
| 06/28/2024 | Q2 2024 | N/A | $1.60 | N/A | $12.45 B | $12.87 B |
| 03/29/2024 | Q1 2024 | N/A | $1.32 | N/A | $11.44 B | $12.12 B |
| 01/31/2024 | Q4 2023 | $1.64 | $4.14 | 2.5 | N/A | $11.78 B |
| 09/30/2023 | Q3 2023 | N/A | $0.85 | N/A | N/A | $12.09 B |
| 06/30/2023 | Q2 2023 | N/A | $1.11 | N/A | N/A | $11.75 B |
| 03/31/2023 | Q1 2023 | N/A | $1.09 | N/A | N/A | $11.05 B |
| 02/01/2023 | Q4 2022 | $1.42 | $0.69 | -0.73 | N/A | $13.09 B |
| 09/29/2022 | Q3 2022 | N/A | $0.73 | N/A | N/A | $10.78 B |
| 06/29/2022 | Q2 2022 | N/A | $0.77 | N/A | N/A | $13.09 B |
| 03/30/2022 | Q1 2022 | N/A | $1.00 | N/A | N/A | $12.81 B |
| 02/02/2022 | Q4 2021 | $1.44 | $7.29 | 5.85 | N/A | $13.52 B |
| 09/29/2021 | Q3 2021 | N/A | $1.23 | N/A | N/A | $13.37 B |
| 06/29/2021 | Q2 2021 | N/A | $1.29 | N/A | N/A | $13.29 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Novartis AG Earnings: FAQ's
The conference call for Novartis AG's latest earnings report can be listened to online.
The conference call transcript for Novartis AG's latest earnings report can be read online.
Novartis AG (:NVS) has a recorded annual revenue of $54.81 B.
Novartis AG (:NVS) has a recorded net income of $14.06 B.Novartis AG has generated $7.25 earnings per share over the last four quarters.
Novartis AG (:NVS) has a price-to-earnings ratio of 21.59 and price/earnings-to-growth ratio is 2.52.